Business Wire

FEELM

27.5.2022 13:40:10 CEST | Business Wire | Press release

Share
FEELM unveils the world's first ceramic coil disposable pod solution at Vaper Expo UK 2022

FEELM, the flagship atomization tech brand belonging to SMOORE, today showcased the world's first ceramic coil disposable pod solution series, FEELM Max at Vaper Expo UK 2022 in Birmingham, UK. By launching the solution and showcasing its cutting-edge ceramic coil heating technology, FEELM is introducing ceramic coil to the emerging category of disposable vape.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220527005197/en/

As a new category in the ascendant, the disposable vape has been growing in popularity since 2020. The market size of disposable (closed system) vaping product has grown to approximately USD2.125 billion in 2021, accounting for 22.7% of global vaping device market share; and it is expected to increase at a GAGR of over 28% from 2022 to 2026, being the fastest-growing category among all vaping products, according to the estimates of Frost & Suvillian. In 2022, the market size of disposable category is expected to reach USD2.72 billion, making up over 43% of closed system vaping products.

However, almost all the existing disposable vapes are equipped with cotton coil, which produces relatively large aerosol particles, leading to inefficient deposition of inhaled particles in the lungs, hence low nicotine delivery and satisfaction, as well as harshness in throat. Soft cotton coils are unable to form a stable structure, hence a high leakage rate and unpleasant burnt taste. Uneven heating of cotton coils could also cause a weak flavor consistency, so that vaping experience will fade gradually. Moreover, the selling points of most disposable vapes currently focus on large-mouth puff count, or rather, the huge number of puffs that the disposable will provide.

To address the three pain points, FEELM unveils the world's first ceramic coil disposable pod solution, FEELM Max is to disposable vapes what internal combustion engine is to airplanes, automobiles, ships, submarines, and trains. It aims to provide the next generation of disposable vapes with a stronger, more reliable and efficient atomization “engine”. Just like internal combustion engine, which features high thermal efficiency, light weight, compact size and maneuverability, marking the coming of the second industrial revolution; FEELM Max is expected to lead another ceramic coil revolution in the global vaping industry, since the launch of FEELM Air in January 2022.

This revolutionary vaping solution has largely improved e-liquid utilization by virtue of a cotton-free structure and microporous ceramic coil. Therefore, its puff number is increased by 25% with the same e-liquid volume, compared with traditional cotton coil disposable vapes. Besides, it can provide an unprecedented silky-smooth vaping experience, thanks to the ceramic coil, which generates smaller vaporized aerosol particles, thereby minimizing residue in throat. In contrast to cotton coil disposable vapes, the smoothness is improved also by 30%. This innovation also boasts extraordinary flavor consistency of over 95%, since ceramic coil can guarantee constant vapor production, so as to bring the same strong and great taste till the last puff.

In addition to the three major benefits, FEELM Max also features 46% increased overall harm reduction performance compared with cotton coil vapes, and ultra-low vaping leakage rate of less than 0.03%, empowered by Maze Leakage-proof Technology. The smaller vaporized aerosol particles generated by FEELM ceramic coil tend to deposit more in the lung, bringing greater and faster satisfaction. Meanwhile, FEELM's patented Flavor-Lock technology can bring tailored flavor release with terraced temperature zones.

In early 2022, FEELM Max has been adopted by a specialist vape retailer in the UK. In partnership with FEELM, this retailer has introduced an ultra-slim disposable product equipped with FEELM ceramic coil. Built to be lightweight and compact, this product is designed specifically for smoking cessation. In April, the two partners participated in VApril 2022, the world’s largest vaping awareness campaign to give away disposable vapes to adult smokers seeking to switch in London and Manchester.

At Vaper Expo UK 2022, FEELM has also showcased other industry-leading, pioneering disposable vaping solutions, for example, eco-friendly non-nicotine disposable e-cigarette and anti-dust mouthpiece hygienic e-cigarette. These two have been awarded Red Dot Awards for Product Design 2022 for their green product concepts and avant-garde design. Unlike traditional disposable e-cigarettes made of plastic, the external structure of eco-friendly non-nicotine disposable e-cigarette is composed of recyclable and reusable paper and aluminum foil while anti-dust mouthpiece hygienic e-cigarette features a twist nozzle to prevent the contact of mouthpiece with something unclean, with the product concept originated from lipsticks.

Another award-winning solution displayed at the event is FEELM Air, the world’s thinnest ceramic coil vape pod solution. In collaboration with its global clients, FEELM has demonstrated a series of vaping products of regional leading brands that adopt FEELM Air solution. Moreover, it will announce the 2022 timeline of commercial launch of FEELM Air on a global scale afterwards.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye